This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Aug 20;93(8):327-328.

doi: 10.1212/WNL.0000000000007965. Epub 2019 Jul 17.

PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?

M J Titulaer¹, S R Irani², H Lassmann²

Affiliations

Affiliations

¹ From the Academic Center for Neuroinflammatory Disorders, Department of Neurology (M.J.T.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences (S.R.I.), University of Oxford, UK; and Center for Brain Research, Department of Neuroimmunology (H.L.), Medical University of Vienna, Austria. m.titulaer@erasmusmc.nl.
² From the Academic Center for Neuroinflammatory Disorders, Department of Neurology (M.J.T.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences (S.R.I.), University of Oxford, UK; and Center for Brain Research, Department of Neuroimmunology (H.L.), Medical University of Vienna, Austria.

PMID: 31315974
DOI: 10.1212/WNL.0000000000007965

Editorial

PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?

M J Titulaer et al. Neurology. 2019.

. 2019 Aug 20;93(8):327-328.

doi: 10.1212/WNL.0000000000007965. Epub 2019 Jul 17.

Authors

M J Titulaer¹, S R Irani², H Lassmann²

Affiliations

¹ From the Academic Center for Neuroinflammatory Disorders, Department of Neurology (M.J.T.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences (S.R.I.), University of Oxford, UK; and Center for Brain Research, Department of Neuroimmunology (H.L.), Medical University of Vienna, Austria. m.titulaer@erasmusmc.nl.
² From the Academic Center for Neuroinflammatory Disorders, Department of Neurology (M.J.T.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences (S.R.I.), University of Oxford, UK; and Center for Brain Research, Department of Neuroimmunology (H.L.), Medical University of Vienna, Austria.

PMID: 31315974
DOI: 10.1212/WNL.0000000000007965

No abstract available

PubMed Disclaimer

Comment on

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.
Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A. Zekeridou A, et al. Neurology. 2019 Aug 20;93(8):e815-e822. doi: 10.1212/WNL.0000000000007971. Epub 2019 Jul 17. Neurology. 2019. PMID: 31315972 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Atypon